Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,917 | -109,577 | -82,642 | -57,217 | -27,059 |
| Depreciation Amortization | 450 | 1,916 | 1,376 | 953 | 493 |
| Accounts payable and accrued liabilities | -522 | 945 | -1,659 | 233 | 294 |
| Other Working Capital | -1,150 | 987 | -284 | 642 | -1,757 |
| Other Operating Activity | 6,431 | 21,338 | 18,816 | 11,330 | 4,864 |
| Operating Cash Flow | $-24,708 | $-84,391 | $-64,393 | $-44,059 | $-23,165 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -70 | -45 | -45 | -39 |
| Purchase Of Investment | -25,075 | -134,700 | -122,681 | -87,033 | -59,003 |
| Sale Of Investment | 25,624 | 159,365 | 140,719 | 110,046 | 65,793 |
| Investing Cash Flow | $549 | $24,595 | $17,993 | $22,968 | $6,751 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 57 | 51,203 | 31,915 | 436 | 196 |
| Other Financing Activity | 0 | -39 | 0 | 0 | 0 |
| Financing Cash Flow | $57 | $51,164 | $31,915 | $436 | $196 |
| Exchange Rate Effect | 16 | -66 | 35 | 14 | 48 |
| Beginning Cash Position | 50,142 | 58,840 | 58,358 | 58,358 | 58,358 |
| End Cash Position | 26,056 | 50,142 | 43,908 | 37,717 | 42,188 |
| Net Cash Flow | $-24,086 | $-8,698 | $-14,450 | $-20,641 | $-16,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,708 | -84,391 | -64,393 | -44,059 | -23,165 |
| Capital Expenditure | N/A | -70 | -45 | -45 | -39 |
| Free Cash Flow | -24,708 | -84,461 | -64,438 | -44,104 | -23,204 |